Your browser doesn't support javascript.
loading
The association between inflammatory biomarkers and low back disorder: a systematic review and meta-analysis.
Sima, Stone; Chen, Xiaolong; Diwan, Ashish D.
Afiliação
  • Sima S; Spine Labs, St George and Sutherland Clinical School, University of New South Wales, Randwick, New South Wales, Australia.
  • Chen X; Spine Labs, St George and Sutherland Clinical School, University of New South Wales, Randwick, New South Wales, Australia.
  • Diwan AD; Department of Orthopaedic Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
Biomarkers ; 29(4): 171-184, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38578280
ABSTRACT

INTRODUCTION:

Low back disorder (LBD) is a major cause of disability worldwide. Inflammation results in proliferation of cytokines or consequent degradation products (collectively known as inflammatory biomarkers) that activate pain pathways which can result in non-specific LBD. This systematic review and meta-analysis aim to evaluate the relationship between inflammatory biomarkers and clinical outcomes in patients with LBD.

METHODS:

The PRISMA guideline was followed for the systematic reivew. Three online databases were searched. Four RCTs and sixteen observational studies with 1142 LBD patients were analysed. The primary outcomes were back and leg pain scores, back-specific disability scores and expression of inflammatory biomarkers. Standardized mean difference (SMD) and their 95% confidence intervals (CI) were evaluated. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was used to summarize the strength of evidence.

RESULTS:

Four RCTs and sixteen observational studies were included in the analysis of 1142 patients with LBD. There was a statistically significant reduction in back pain score and IL-1 beta and increase in the expression of CTX-1 and IL-10 levels post treatment. There was a significant relationship between increase in the expression of MCP- and reduction in the expression of hsCRP with increase in back pain. Significant relationship was also observed between increase in the expression of MCP-1 and reduction in the expression of IL-6 with increase in leg pain. Increase in the expression of IL-8 and reduction in the expression of hsCRP was also associated with increased disability score.

CONCLUSION:

Inflammatory biomarkers play a significant role in the pathogenesis of LBD. CTX-1, IL-10 and IL-1 beta may be responsible for the decrease in back pain scores post treatment. There is a relationship between MCP-1, IL-6, IL-8 and hsCRP with clinical and functional assessments for LBD. Further studies will improve understanding of the pathogenesis of LBD and aid in targeted management strategies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Dor Lombar / Inflamação Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores / Dor Lombar / Inflamação Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article